Esteve
Focus: Esteve is a Barcelona-based biotech company focused on small molecules and gene therapy, with a legacy portfolio concentrated in rare endocrine disorders. The company operates as a specialty pharma player with a modest clinical pipeline and significant revenue dependency on two aging assets.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Esteve
AI assessmentNot HiringNo open roles listed right now. Follow Esteve to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Esteve's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$2M Part DDeclining
LOE Approaching
Cornerstone asset generating 68% of company revenue; loss of exclusivity poses immediate strategic and cash-flow risk.
Help build intelligence for Esteve
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.